| 08/08 | Mersana Therapeutics Announces Option Agreement with GSK for the Co-Development and Com.. |  |
| 08/08 | GlaxoSmithKline, IQVIA Introduce Vaccination Data Tracker | |
| 08/08 | GSK plc and IQVIA launch Vaccine Track | |
| 08/08 | ADDING MULTIMEDIA GSK and IQVIA launch Vaccine Track, a data trend platform to help imp.. | |
| 08/08 | El FTSE 100 sube por las ganancias de los valores petroleros, industriales y financiero.. |  |
| 08/08 | GSK : Ubs cuts target price to 1820p from 1860p… | |
| 08/08 | Climate change puts Lyme disease in focus for France's Valneva after COVID blow | |
| 05/08 | UK Financial Watchdog Fines Ex-ConvaTec Chair For Sharing Inside Information | |
| 05/08 | GSK : Morgan stanley resumes coverage with equal weight; target p… | |
| 03/08 | European ADRs Nudge Higher in Wednesday Trading | |
| 03/08 | GLAXOSMITHKLINE : GSK Announces Offer to Repurchase Exchangeable Senior Notes Due 2023 - F.. | |
| 03/08 | GSK Offers to Buy Back $280 Million of 2023 Notes | |
| 03/08 | GSK Announces Offer To Repurchase Exchangeable Senior Notes Due 2023 | |
| 03/08 | Gsk - its wholly owned unit, gsk finance plc, is offering to rep… | |
| 03/08 | Gsk announces offer to repurchase exchangeable senior notes due… | |
| 02/08 | COVID : Ue sigla contratto con Hipra per 250 mln dosi vaccino |  |
| 01/08 | GLAXOSMITHKLINE : Director/Pdmr Shareholding - Form 6-K | |
| 29/07 | GLAXOSMITHKLINE : GSK Board change - Form 6-K | |
| 29/07 | GLAXOSMITHKLINE : Q2 2022 results transcript (PDF - 477.6KB) | |
| 29/07 | GSK Says Laurie Glimcher Has Advised Co Of Her Intention To Retire | |
| 29/07 | Laurie Glimcher Advises GSK of Intention to Retire from the Board on 13 October 2022 | |
| 29/07 | GSK Unit ViiV Healthcare's HIV Prevention Drug Shows Lower Rate Of New Infections Among.. | |
| 29/07 | GSK's ViiV Healthcare Strikes Deal to Allow Generic Versions of HIV Prevention Drug in .. | |
| 28/07 | GlaxoSmithKline-backed ViiV Healthcare Enters Licensing Deal With Medicines Patent Pool.. | |
| 28/07 | GLOBAL MARKETS LIVE : Best Buy, Diageo, Mastercard, Pfizer, Qualcomm... | |
| 28/07 | Cheap copies of GSK's HIV prevention drug could be ready in 2026 | |
| 28/07 | Copias genéricas del medicamento de GSK para prevenir el VIH podrían estar listas en 20.. | |
| 28/07 | Cheap copies of GSK's HIV prevention drug could be ready in 2026 | |
| 28/07 | GLAXOSMITHKLINE : ViiV Healthcare announces new data at AIDS 2022 from unblinded phase of .. | |
| 28/07 | EU sichert Millionen Dosen Grippe-Impfstoff gegen mögliche Pandemie |  |
| 28/07 | EU sichert sich bis zu 85 Millionen Dosen Grippe-Impfstoff | |
| 28/07 | GSK Signs Framework Contract With EU For Future Pandemic Vaccine | |
| 28/07 | GLAXOSMITHKLINE : GSK signs agreement to support pandemic preparedness in Europe | |
| 28/07 | Analysis-As inflation soars, European consumer goods M&A slows | |
| 27/07 | GlaxoSmithKline's Lupus Nephritis Drug Secures US FDA Approval for Treatment of Childre.. | |
| 27/07 | GSK says U.S. FDA approves kidney disease drug for children | |
| 27/07 | GSK says U.S. FDA approves kidney disease drug for children | |
| 27/07 | GSK Gets US FDA Approval Of Benlysta For Pediatric Patients With Active Lupus Nephritis | |
| 27/07 | GSK Announces US FDA Approval of Benlysta (Belimumab) for Pediatric Patients With Activ.. | |
| 27/07 | GSK plc Announces US Food and Drug Administration Approval of Benlysta for Pediatric Pa.. | |
| 27/07 | GLOBAL MARKETS LIVE : Adidas, Alphabet, Chipotle, Spotify, Shopify... | |
| 27/07 | GSK Lupus Treatment Approved for Pediatric Patients by U.S. FDA | |
| 27/07 | FTSE 100 Closes Wednesday Up on Positive Earnings Reports | |
| 27/07 | GLAXOSMITHKLINE : Q2 2022 US dollar translation ( - 0b) | |
| 27/07 | ¿Crisis del coste de la vida? Los consumidores europeos siguen gastando | |
| 27/07 | Cost of living crisis? Europe's consumers keep spending | |
| 27/07 | MIDDAY BRIEFING - Unternehmen und Märkte -2- | |
| 27/07 | Gsk plc Provides Dividend Guidance for Second Half 2022 and for full year 2023 | |
| 27/07 | TRANSCRIPT : GSK plc, Q2 2022 Earnings Call, Jul 27, 2022 | |
| 27/07 | GSK Posts Higher Q2 Adjusted Earnings, Sales | |
| 27/07 | Lloyds Banking's Scope for Shareholder Returns Improves, Says Barclays | |
| 27/07 | GSK hebt nach deutlichem Gewinnanstieg Prognose an | |
| 27/07 | GSK CEO : "world has started to recognize that adult vaccination… | |
| 27/07 | FTSE 100 Gains as Lloyds, Oil Majors Rise; Rio Tinto Disappoints | |
| 27/07 | GSK CEO : "the great growth that we have reported this year is v… | |
| 27/07 | GSK CEO : "our industry is less exposed than many other industri… | |
| 27/07 | GSK CEO : Co focused on the future of vaccines in an endemic cov… | |
| 27/07 | GSK CEO : Co has more appetite for m&a… | |
| 27/07 | GSK CEO : Co not currently in any discussions with any other co… | |
| 27/07 | GSK Banks on Vaccines, Specialty Medicines to Achieve Upgraded 2022 Targets Post-Haleon.. | |
| 27/07 | CORRECTION : GSK's H1 Profit Rises On Strong Growth In Product Groups, Turnover | |
| 27/07 | Rio Tinto Dividend Miss Sours Earnings Beat | |
| 27/07 | FTSE 100 to Open Higher With Focus on Fed | |
| 27/07 | GSK 2Q Operating Profit Slipped Despite Higher Sales; Raises 2022 Outlook -- Update | |
| 27/07 | GLAXOSMITHKLINE : Q2 2022 results slides | |
| 27/07 | GLAXOSMITHKLINE : Q2 2022 clinical trials summary (PDF - 999.2KB) | |
| 27/07 | GLAXOSMITHKLINE : Q2 2022 results infographic (PDF - 87.4KB) | |
| 27/07 | GUTE IMPFSTOFFNACHFRAGE : GlaxoSmithKline hebt Jahresziele an | |
| 27/07 | Haleon Sees Up to 8% Organic Revenue Growth in FY22 After H1 Rise | |
| 27/07 | Haleon 2Q Organic Revenue Boosted by Portfolio Strength, Innovation | |
| 27/07 | GSK's H1 Profit Rises On Strong Growth In Product Groups, Commercial Operations Turnove.. | |
| 27/07 | GSK 2Q Operating Profit Slipped Despite Higher Sales; Raises 2022 Outlook | |
| 27/07 | GLAXOSMITHKLINE : GSK delivers strong Q2 2022 sales of £6.9 billion +19% at AER, +13% at C.. | |
| 27/07 | GSK lifts full-year forecast, days after consumer health spinoff | |
| 27/07 | GLAXOSMITHKLINE : Q2 2022 results announcement (PDF - 1.5MB) | |
English (USA)
English (UK)
English (Canada)
Deutsch (Deutschland)
Deutsch (Schweiz)
Español
Italiano
Nederlands (Nederland)
Nederlands (België)
bourse
Rapport
